Warrandyte, Australia

Douglas James Hilton



Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 188(Granted Patents)


Location History:

  • Victoria, AU (1998)
  • Warrandyte, AU (1992 - 2012)

Company Filing History:


Years Active: 1992-2012

Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: **Douglas James Hilton: Innovator in Antibody Research**

Introduction

Douglas James Hilton is a prominent inventor based in Warrandyte, Australia. With an impressive portfolio of 23 patents, Hilton has made significant contributions to the field of biomedical research, particularly in the development of therapeutic antibodies.

Latest Patents

Among his latest inventions, Hilton has focused on the creation of monoclonal antibodies targeting the interleukin-13 receptor alpha 1 (IL-13Ralpha1). The present inventions relate to antibodies that bind specifically to the IL-13 receptor alpha 1 chain, effectively antagonizing IL-13 receptor-mediated signaling pathways triggered by IL-13 and/or IL-4.

These humanized or human antibodies are designed for use in the treatment or prevention of various IL-13- and IL-4-mediated diseases or conditions. Additionally, Hilton's inventions include methods for modulating these conditions through the administration of the patented antibodies. He also provides an assay system useful for identifying other agents that can modulate IL-13 and IL-4 signaling, further enhancing the therapeutic landscape.

Career Highlights

Hilton has built a remarkable career at esteemed organizations, including the Walter and Eliza Hall Institute of Medical Research and Amrad Corporation Limited. His work at these institutions has significantly pushed forward the boundaries of medical research, particularly in immunology and therapeutic interventions.

Collaborations

Throughout his career, Hilton has collaborated with notable colleagues such as Nicos Anthony Nicola and Tracy Ann Willson. These partnerships have fostered innovation and excellence in the biomedical field, contributing to advancements in therapeutic antibody development.

Conclusion

Douglas James Hilton's continuing efforts in antibody research underscore his status as an influential inventor in the biomedical landscape. Through his innovative patents and collaborative career, he is paving the way for new treatments and therapeutic strategies against diseases caused by IL-13 and IL-4 signaling. His work exemplifies the crucial role of inventors in advancing healthcare and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…